Rousselot, Darling Ingredients’ health brand, has been granted patents in Europe, Japan and China for Colartix, it...
Since the introduction of Chapter 18A in 2018, Hong Kong has become an important fundraising hub for biotechnology, givi...
ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organizati...
Hong Kong Metropolitan University (HKMU) recently achieved its first-ever technology licensing agreement, a milestone in...
Neusoft Medical Systems has announced that its NeuViz P10 photon-counting CT has received market approval from China's N...
Developing effective antiviral drugs against mosquito-borne viruses like dengue and Zika requires understanding the func...
Sustainable drug manufacturing is becoming increasingly vital in the global pharmaceutical industry, as drugmakers ...
The Hong Kong Polytechnic University (PolyU) has signed an agreement with Panmedi to further collaborate&...
Robocore Technology Limited (Robocore), a partner company of Hong Kong Science and Technology Parks Corporation (HKSTP),...
Eisai Co. has announced that the in-house discovered and developed orexin receptor antagonist DAYVIGO® (brand name i...
A research team from Hong Kong Baptist University (HKBU) has successfully developed a “Sequential Measurement Base...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
China-based Kexing Biopharm has entered into a comprehensive strategic partnership with IQVIA, a global leader...
China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...
Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, has announced an exclusive collaboratio...
Biocair, an established global leader in life science logistics, has announced further expansion of its operations in th...
XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials...
Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...
